Literature DB >> 1322695

Structure of the bis divalent cation complex with phosphonoacetohydroxamate at the active site of enolase.

R R Poyner1, G H Reed.   

Abstract

Phosphonoacetohydroxamate (PhAH) is a tight-binding (Ki = 15 pM) inhibitor of enolase that is believed to mimic the aci-carboxylate form of the intermediate carbanion in the reaction [Anderson, V. E., Weiss, P. M., & Cleland, W. W. (1984) Biochemistry 23, 2779]. Electron paramagnetic resonance (EPR) spectroscopy of Mn2+ has been used to map sites of interaction of PhAH with the two divalent cations at the active site of enolase from bakers' yeast. EPR spectra of enolase-PhAH complexes containing two Mn2+ bound at the active site contain multiple fine structure transitions each with a 45-G 55Mn hyperfine spacing that is a characteristic of spin exchange coupled pairs of Mn2+. Magnetically dilute complexes were obtained by preparation of specific Mg2+/Mn2+ hybrid complexes by manipulating the order of addition of the divalent metal species. Thus, Mn2+ was placed in the higher affinity site by addition of 1 equiv of Mn2+ to a solution of enolase and PhAH, followed by addition of 1 equiv of Mg2+. Reversing the order of addition of Mg2+ and Mn2+ placed Mn2+ in the lower affinity site. Regiospecifically 17O-labeled forms of PhAH were prepared, and the binding of the functional groups on PhAH to Mn2+ at the two metal ion sites was determined from the presence or absence of 17O superhyperfine coupling in the EPR signals. The hydroxamate oxygen is a ligand of Mn2+ at the higher affinity site, a phosphonate oxygen is a ligand of Mn2+ at the lower affinity site, and the carbonyl oxygen is a mu-O bridge of the two metal ions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322695     DOI: 10.1021/bi00146a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Evolution of an enzyme active site: the structure of a new crystal form of muconate lactonizing enzyme compared with mandelate racemase and enolase.

Authors:  M S Hasson; I Schlichting; J Moulai; K Taylor; W Barrett; G L Kenyon; P C Babbitt; J A Gerlt; G A Petsko; D Ringe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

2.  Structure of mandelate racemase with bound intermediate analogues benzohydroxamate and cupferron.

Authors:  Adam D Lietzan; Mitesh Nagar; Elise A Pellmann; Jennifer R Bourque; Stephen L Bearne; Martin St Maurice
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

3.  Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.

Authors:  Zhengnan Huang; Yilin Yan; Tengjiao Wang; Zeyi Wang; Jinming Cai; Xiangqian Cao; Chenkai Yang; Fang Zhang; Gang Wu; Bing Shen
Journal:  J Transl Med       Date:  2022-07-14       Impact factor: 8.440

4.  Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions.

Authors:  Elsje Pienaar; William M Matern; Jennifer J Linderman; Joel S Bader; Denise E Kirschner
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

5.  The catalytic Mn2+ sites in the enolase-inhibitor complex: crystallography, single-crystal EPR, and DFT calculations.

Authors:  Raanan Carmieli; Todd M Larsen; George H Reed; Samir Zein; Frank Neese; Daniella Goldfarb
Journal:  J Am Chem Soc       Date:  2007-03-17       Impact factor: 15.419

6.  Passenger deletions generate therapeutic vulnerabilities in cancer.

Authors:  Florian L Muller; Simona Colla; Elisa Aquilanti; Veronica E Manzo; Giannicola Genovese; Jaclyn Lee; Daniel Eisenson; Rujuta Narurkar; Pingna Deng; Luigi Nezi; Michelle A Lee; Baoli Hu; Jian Hu; Ergun Sahin; Derrick Ong; Eliot Fletcher-Sananikone; Dennis Ho; Lawrence Kwong; Cameron Brennan; Y Alan Wang; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

7.  SF2312 is a natural phosphonate inhibitor of enolase.

Authors:  Paul G Leonard; Nikunj Satani; David Maxwell; Yu-Hsi Lin; Naima Hammoudi; Zhenghong Peng; Federica Pisaneschi; Todd M Link; Gilbert R Lee; Duoli Sun; Basvoju A Bhanu Prasad; Maria Emilia Di Francesco; Barbara Czako; John M Asara; Y Alan Wang; William Bornmann; Ronald A DePinho; Florian L Muller
Journal:  Nat Chem Biol       Date:  2016-10-10       Impact factor: 15.040

8.  ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase.

Authors:  Nikunj Satani; Yu-Hsi Lin; Naima Hammoudi; Sudhir Raghavan; Dimitra K Georgiou; Florian L Muller
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.